COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter

Affiliations

¹ Department of Medicine, Division of hematology, Oncology and Cell Therapy, The Coleman Foundation Blood and Marrow Transplant Center at Rush University Medical Center, Chicago, IL, USA. Ankur_Varma@rush.edu.
² Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA.
³ Department of Medicine, Division of hematology, Oncology and Cell Therapy, The Coleman Foundation Blood and Marrow Transplant Center at Rush University Medical Center, Chicago, IL, USA.
⁴ Bone Marrow Transplant and Cellular Therapy Program, Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA.
⁵ Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

^# Contributed equally.

Comment

Ankur Varma et al. Leukemia. 2020 Oct.

. 2020 Oct;34(10):2809-2812.

doi: 10.1038/s41375-020-01019-x. Epub 2020 Aug 14.

¹ Department of Medicine, Division of hematology, Oncology and Cell Therapy, The Coleman Foundation Blood and Marrow Transplant Center at Rush University Medical Center, Chicago, IL, USA. Ankur_Varma@rush.edu.
² Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA.
³ Department of Medicine, Division of hematology, Oncology and Cell Therapy, The Coleman Foundation Blood and Marrow Transplant Center at Rush University Medical Center, Chicago, IL, USA.
⁴ Bone Marrow Transplant and Cellular Therapy Program, Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA.
⁵ Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

^# Contributed equally.

No abstract available

Conflict of interest statement

The authors declare that they have no conflict of interest.

COVID-19 in persons with haematological cancers.
He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, Wu D, Liang B, Lu X, Ma Y, Li L, Wang H, Chen Z, Li Q, Gale RP. He W, et al. Leukemia. 2020 Jun;34(6):1637-1645. doi: 10.1038/s41375-020-0836-7. Epub 2020 Apr 24. Leukemia. 2020. PMID: 32332856 Free PMC article.

1. He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, et al. COVID-19 in persons with haematological cancers. Leukemia. 2020;34:1637–45. doi: 10.1038/s41375-020-0836-7. - DOI - PMC - PubMed
1. Hatzl S, Eisner F, Schilcher G, Kreuzer P, Gornicec M, Eller P, et al. Response to “COVID-19 in persons with haematological cancers.” Leukemia. 2020. http://www.nature.com/articles/s41375-020-0914-x. - PMC - PubMed
1. Dhakal B, D’Souza A, Chhabra S, Hari P. Multiple myeloma and COVID-19. Leukemia. 2020;34:1961–3. doi: 10.1038/s41375-020-0879-9. - DOI - PubMed
1. van Doesum J, Chinea A, Pagliaro M, Pasquini MC, van Meerten T, Bakker M, et al. Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands. Leukemia. 2020. http://www.nature.com/articles/s41375-020-0960-4. - PMC - PubMed
1. Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395:1907–18. doi: 10.1016/S0140-6736(20)31187-9. - DOI - PMC - PubMed